Immuron Q3 Sales reach 150% of 1H Sales

Highlights: Australian Q3 FY23 sales of A$577 k North American Q3 FY23 Travelan® sales of A$298 k Global Q3 YTD FY23 sales of A$1.46 M represent an increase of 239% compared with the... | April 6, 2023

Related Keywords

Canada ,Australia ,United States ,Melbourne ,Victoria ,Australian ,American ,Steven Lydeamore ,Nasdaq ,Immuron Limited ,Australian Bureau Of Statistics ,Passport Health Travel Clinics ,Australian Bureau ,North American ,Australian Register ,Therapeutic Goods ,Traveler Diarrhea ,Immuron Limited Stock Exchange ,News ,Information ,Press Release ,3 ,Y23 ,Sales ,F , ,North ,Lobal ,Td ,Epresent ,N ,Increase ,Ompared ,Ith Imc Au000000imc7 ,